These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 29374347)
1. Association between preoperative thyrotrophin and clinicopathological and aggressive features of papillary thyroid cancer. Tam AA; Ozdemir D; Aydın C; Bestepe N; Ulusoy S; Sungu N; Ersoy R; Cakir B Endocrine; 2018 Mar; 59(3):565-572. PubMed ID: 29374347 [TBL] [Abstract][Full Text] [Related]
2. Thyrotropin (TSH) and thyroid autoimmunity are predictive factors for the incidental discovery of papillary thyroid microcarcinoma during thyroidectomy. Kyrilli A; Schoinochoriti R; Chatzopoulos V; Bahar N; Bouziotis J; D'Haene N; Salmon I; Ruiz M; Corvilain B Endocrine; 2024 Nov; 86(2):723-731. PubMed ID: 38896365 [TBL] [Abstract][Full Text] [Related]
3. Low serum 25 hydroxyvitamin D is associated with poor clinicopathologic characteristics in female patients with papillary thyroid cancer. Kim JR; Kim BH; Kim SM; Oh MY; Kim WJ; Jeon YK; Kim SS; Lee BJ; Kim YK; Kim IJ Thyroid; 2014 Nov; 24(11):1618-24. PubMed ID: 25133449 [TBL] [Abstract][Full Text] [Related]
4. Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors. Shi C; Guo Y; Lv Y; Nanding A; Shi T; Qin H; He J PLoS One; 2016; 11(12):e0167414. PubMed ID: 27936049 [TBL] [Abstract][Full Text] [Related]
5. Association between preoperative serum TSH and tumor status in patients with papillary thyroid microcarcinoma. Mao A; An N; Wang J; Wu Y; Wang T; Wang Z; Guan H; Wang J Endocrine; 2021 Sep; 73(3):617-624. PubMed ID: 33755880 [TBL] [Abstract][Full Text] [Related]
6. Factors associated with postoperative hypothyroidism after lobectomy in papillary thyroid microcarcinoma patients. Park HK; Kim DW; Ha TK; Choo HJ; Park YM; Jung SJ; Kim DH; Bae SK Endocr Res; 2015; 40(1):49-53. PubMed ID: 25111668 [TBL] [Abstract][Full Text] [Related]
7. High Serum TSH Level Is Associated With Progression of Papillary Thyroid Microcarcinoma During Active Surveillance. Kim HI; Jang HW; Ahn HS; Ahn S; Park SY; Oh YL; Hahn SY; Shin JH; Kim JH; Kim JS; Chung JH; Kim TH; Kim SW J Clin Endocrinol Metab; 2018 Feb; 103(2):446-451. PubMed ID: 29211863 [TBL] [Abstract][Full Text] [Related]
8. Combination of serum microRNAs and ultrasound profile as predictive biomarkers of diagnosis and prognosis for papillary thyroid microcarcinoma. Zhang Y; Pan J; Xu D; Yang Z; Sun J; Sun L; Wu Y; Qiao H Oncol Rep; 2018 Dec; 40(6):3611-3624. PubMed ID: 30542708 [TBL] [Abstract][Full Text] [Related]
9. Risk factors contributing to the difference in prognosis for papillary versus micropapillary thyroid carcinoma. Karatzas T; Vasileiadis I; Kapetanakis S; Karakostas E; Chrousos G; Kouraklis G Am J Surg; 2013 Oct; 206(4):586-93. PubMed ID: 23790258 [TBL] [Abstract][Full Text] [Related]
10. Thyroglobulin antibodies could be a potential predictive marker for papillary thyroid carcinoma. Vasileiadis I; Boutzios G; Charitoudis G; Koukoulioti E; Karatzas T Ann Surg Oncol; 2014 Aug; 21(8):2725-32. PubMed ID: 24595799 [TBL] [Abstract][Full Text] [Related]
11. RET/PTC Rearrangements Are Associated with Elevated Postoperative TSH Levels and Multifocal Lesions in Papillary Thyroid Cancer without Concomitant Thyroid Benign Disease. Su X; He C; Ma J; Tang T; Zhang X; Ye Z; Long Y; Shao Q; Shao J; Yang A PLoS One; 2016; 11(11):e0165596. PubMed ID: 27802347 [TBL] [Abstract][Full Text] [Related]
12. Thyrotropin serum concentrations in patients with papillary thyroid microcancers. Gerschpacher M; Göbl C; Anderwald C; Gessl A; Krebs M Thyroid; 2010 Apr; 20(4):389-92. PubMed ID: 20210672 [TBL] [Abstract][Full Text] [Related]
13. [Clinical analysis of lymphocytic thyroiditis coexistent with papillary thyroid carcinoma]. Wang SX; She ZQ; An CM; Zhang XW; Li ZJ; Tang PZ Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Apr; 51(4):277-81. PubMed ID: 27095720 [TBL] [Abstract][Full Text] [Related]
14. Lack of association between high serum thyroid-stimulating hormone level and risk of papillary thyroid microcarcinomas. Sohn SY; Kim HJ; Jang HW; Kim SW; Chung JH Head Neck; 2014 Jan; 36(1):43-6. PubMed ID: 23728859 [TBL] [Abstract][Full Text] [Related]
15. Hashimoto's thyroiditis as a risk factor of papillary thyroid cancer may improve cancer prognosis. Lun Y; Wu X; Xia Q; Han Y; Zhang X; Liu Z; Wang F; Duan Z; Xin S; Zhang J Otolaryngol Head Neck Surg; 2013 Mar; 148(3):396-402. PubMed ID: 23300224 [TBL] [Abstract][Full Text] [Related]
16. High TPOAb Levels (>1300 IU/mL) Indicate Multifocal PTC in Hashimoto's Thyroiditis Patients and Support Total Thyroidectomy. Dong S; Xia Q; Wu YJ Otolaryngol Head Neck Surg; 2015 Jul; 153(1):20-6. PubMed ID: 25917667 [TBL] [Abstract][Full Text] [Related]
17. Bilateral versus unilateral papillary thyroid microcarcinoma: predictive factors and associated histopathological findings following total thyroidectomy. Karatzas T; Vasileiadis I; Charitoudis G; Karakostas E; Tseleni-Balafouta S; Kouraklis G Hormones (Athens); 2013; 12(4):529-36. PubMed ID: 24457401 [TBL] [Abstract][Full Text] [Related]
18. CIRCULATING THYROID-STIMULATING HORMONE RECEPTOR MESSENGER RNA AS A MARKER OF TUMOR AGGRESSIVENESS IN PATIENTS WITH PAPILLARY THYROID MICROCARCINOMA. Aliyev A; Gupta M; Nasr C; Hatipoglu B; Milas M; Siperstein A; Berber E Endocr Pract; 2015 Jul; 21(7):777-81. PubMed ID: 25786552 [TBL] [Abstract][Full Text] [Related]
19. Coexistence of thyroglobulin antibodies and thyroid peroxidase antibodies correlates with elevated thyroid-stimulating hormone level and advanced tumor stage of papillary thyroid cancer. Wu X; Lun Y; Jiang H; Gang Q; Xin S; Duan Z; Zhang J Endocrine; 2014 Aug; 46(3):554-60. PubMed ID: 24338678 [TBL] [Abstract][Full Text] [Related]
20. Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role. Fiore E; Rago T; Provenzale MA; Scutari M; Ugolini C; Basolo F; Di Coscio G; Berti P; Grasso L; Elisei R; Pinchera A; Vitti P Endocr Relat Cancer; 2009 Dec; 16(4):1251-60. PubMed ID: 19528244 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]